Oui, la myomectomie est une chirurgie invasive, mais elle préserve l'utérus.
Chirurgie invasiveMyomectomieFibromes utérins
Complications
5
#1
Quelles sont les complications possibles de la myomectomie ?
Les complications peuvent inclure des infections, des saignements et des cicatrices.
ComplicationsMyomectomieInfections
#2
La myomectomie peut-elle affecter la fertilité ?
Dans certains cas, la myomectomie peut affecter la fertilité, mais elle préserve souvent l'utérus.
FertilitéMyomectomieFibromes utérins
#3
Quels sont les risques d'infection après une myomectomie ?
Les infections peuvent survenir, mais elles sont généralement rares avec des soins appropriés.
InfectionsMyomectomieSoins postopératoires
#4
Peut-on avoir des saignements après la myomectomie ?
Oui, des saignements peuvent survenir après l'intervention, mais ils doivent être surveillés.
SaignementsMyomectomieComplications
#5
Quelles sont les complications à long terme ?
Les complications à long terme peuvent inclure des douleurs chroniques ou des problèmes menstruels.
ComplicationsDouleurs chroniquesFibromes utérins
Facteurs de risque
5
#1
Quels sont les facteurs de risque des fibromes ?
Les facteurs incluent l'âge, l'obésité, les antécédents familiaux et les hormones.
Facteurs de risqueFibromes utérinsObésité
#2
Les antécédents familiaux influencent-ils les fibromes ?
Oui, avoir des membres de la famille avec des fibromes augmente le risque.
Antécédents familiauxFibromes utérinsFacteurs de risque
#3
L'âge est-il un facteur de risque pour les fibromes ?
Oui, les fibromes sont plus fréquents chez les femmes de 30 à 40 ans.
ÂgeFibromes utérinsFacteurs de risque
#4
Le surpoids augmente-t-il le risque de fibromes ?
Oui, le surpoids et l'obésité sont associés à un risque accru de fibromes.
ObésitéFibromes utérinsFacteurs de risque
#5
Les hormones influencent-elles le développement des fibromes ?
Oui, les déséquilibres hormonaux, notamment des œstrogènes, peuvent favoriser leur développement.
HormonesFibromes utérinsFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Myomectomie de l'utérus : Questions médicales les plus fréquentes",
"headline": "Myomectomie de l'utérus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Myomectomie de l'utérus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-31",
"dateModified": "2026-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Myomectomie de l'utérus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Procédures de chirurgie gynécologique",
"url": "https://questionsmedicales.fr/mesh/D013509",
"about": {
"@type": "MedicalCondition",
"name": "Procédures de chirurgie gynécologique",
"code": {
"@type": "MedicalCode",
"code": "D013509",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.950.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Myomectomie de l'utérus",
"alternateName": "Uterine Myomectomy",
"code": {
"@type": "MedicalCode",
"code": "D063186",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Isaac Manyonda",
"url": "https://questionsmedicales.fr/author/Isaac%20Manyonda",
"affiliation": {
"@type": "Organization",
"name": "From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom."
}
},
{
"@type": "Person",
"name": "Versha Cheed",
"url": "https://questionsmedicales.fr/author/Versha%20Cheed",
"affiliation": {
"@type": "Organization",
"name": "From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom."
}
},
{
"@type": "Person",
"name": "Olivia Wu",
"url": "https://questionsmedicales.fr/author/Olivia%20Wu",
"affiliation": {
"@type": "Organization",
"name": "From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom."
}
},
{
"@type": "Person",
"name": "Fusun Sirkeci",
"url": "https://questionsmedicales.fr/author/Fusun%20Sirkeci",
"affiliation": {
"@type": "Organization",
"name": "From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom."
}
},
{
"@type": "Person",
"name": "Klim McPherson",
"url": "https://questionsmedicales.fr/author/Klim%20McPherson",
"affiliation": {
"@type": "Organization",
"name": "From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Hysteroscopic management of uterine diverticulum after myomectomy: a case report.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37641054",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12905-023-02606-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37286130",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmig.2023.06.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparing the effect of FUAS and myomectomy on the elasticity of myometrium around targeted uterine fibroid.",
"datePublished": "2024-08-11",
"url": "https://questionsmedicales.fr/article/39128847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02656736.2024.2362998"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids.",
"datePublished": "2024-08-20",
"url": "https://questionsmedicales.fr/article/39164326",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-69754-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Triple vs. single uterine tourniquet to reduce hemorrhage at myomectomy: a randomized trial.",
"datePublished": "2023-09-06",
"url": "https://questionsmedicales.fr/article/37672088",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07201-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Procédures de chirurgie opératoire",
"item": "https://questionsmedicales.fr/mesh/D013514"
},
{
"@type": "ListItem",
"position": 3,
"name": "Procédures de chirurgie urogénitale",
"item": "https://questionsmedicales.fr/mesh/D013519"
},
{
"@type": "ListItem",
"position": 4,
"name": "Procédures de chirurgie gynécologique",
"item": "https://questionsmedicales.fr/mesh/D013509"
},
{
"@type": "ListItem",
"position": 5,
"name": "Myomectomie de l'utérus",
"item": "https://questionsmedicales.fr/mesh/D063186"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Myomectomie de l'utérus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Myomectomie de l'utérus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Myomectomie de l'utérus",
"description": "Comment diagnostiquer des fibromes utérins ?\nQuels sont les symptômes des fibromes ?\nLes fibromes peuvent-ils être asymptomatiques ?\nQuels examens sont nécessaires avant une myomectomie ?\nLes fibromes peuvent-ils causer des complications ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Myomectomie de l'utérus",
"description": "Quels sont les signes d'un fibrome utérin ?\nLes fibromes peuvent-ils affecter la fertilité ?\nComment les fibromes affectent-ils les menstruations ?\nPeut-on ressentir des douleurs pendant les rapports ?\nLes fibromes peuvent-ils provoquer des problèmes urinaires ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Myomectomie de l'utérus",
"description": "Peut-on prévenir les fibromes utérins ?\nLes facteurs hormonaux influencent-ils les fibromes ?\nL'alimentation joue-t-elle un rôle dans les fibromes ?\nLe stress peut-il aggraver les fibromes ?\nL'exercice régulier aide-t-il à prévenir les fibromes ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Myomectomie de l'utérus",
"description": "Quelles sont les options de traitement pour les fibromes ?\nQuand est-il nécessaire de faire une myomectomie ?\nQuels médicaments peuvent traiter les fibromes ?\nQu'est-ce que l'embolisation des artères utérines ?\nLa myomectomie est-elle une chirurgie invasive ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Myomectomie de l'utérus",
"description": "Quelles sont les complications possibles de la myomectomie ?\nLa myomectomie peut-elle affecter la fertilité ?\nQuels sont les risques d'infection après une myomectomie ?\nPeut-on avoir des saignements après la myomectomie ?\nQuelles sont les complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Myomectomie de l'utérus",
"description": "Quels sont les facteurs de risque des fibromes ?\nLes antécédents familiaux influencent-ils les fibromes ?\nL'âge est-il un facteur de risque pour les fibromes ?\nLe surpoids augmente-t-il le risque de fibromes ?\nLes hormones influencent-elles le développement des fibromes ?",
"url": "https://questionsmedicales.fr/mesh/D063186#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer des fibromes utérins ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fibromes sont souvent diagnostiqués par échographie ou IRM pelvique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des fibromes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des saignements menstruels abondants, douleurs pelviennes et pression."
}
},
{
"@type": "Question",
"name": "Les fibromes peuvent-ils être asymptomatiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses femmes avec des fibromes ne présentent aucun symptôme."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires avant une myomectomie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen pelvien, échographie et éventuellement une hystéroscopie sont requis."
}
},
{
"@type": "Question",
"name": "Les fibromes peuvent-ils causer des complications ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des complications comme l'anémie due à des saignements."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'un fibrome utérin ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs abdominales, des saignements irréguliers et des ballonnements."
}
},
{
"@type": "Question",
"name": "Les fibromes peuvent-ils affecter la fertilité ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains fibromes peuvent interférer avec la fertilité ou la grossesse."
}
},
{
"@type": "Question",
"name": "Comment les fibromes affectent-ils les menstruations ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des menstruations plus longues et plus abondantes."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des douleurs pendant les rapports ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fibromes peuvent causer des douleurs pendant les rapports sexuels."
}
},
{
"@type": "Question",
"name": "Les fibromes peuvent-ils provoquer des problèmes urinaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent exercer une pression sur la vessie, entraînant des problèmes urinaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les fibromes utérins ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie pour prévenir les fibromes, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Les facteurs hormonaux influencent-ils les fibromes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les œstrogènes et la progestérone peuvent favoriser la croissance des fibromes."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les fibromes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits et légumes peut réduire le risque de fibromes."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les fibromes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut influencer les niveaux hormonaux, potentiellement aggravant les fibromes."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les fibromes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut aider à maintenir un poids santé et réduire le risque."
}
},
{
"@type": "Question",
"name": "Quelles sont les options de traitement pour les fibromes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent la myomectomie, les médicaments et l'embolisation des artères utérines."
}
},
{
"@type": "Question",
"name": "Quand est-il nécessaire de faire une myomectomie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une myomectomie est recommandée si les fibromes causent des symptômes significatifs."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent traiter les fibromes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments hormonaux comme les progestatifs peuvent aider à réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'embolisation des artères utérines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une procédure qui bloque le flux sanguin vers les fibromes, les réduisant."
}
},
{
"@type": "Question",
"name": "La myomectomie est-elle une chirurgie invasive ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la myomectomie est une chirurgie invasive, mais elle préserve l'utérus."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la myomectomie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des saignements et des cicatrices."
}
},
{
"@type": "Question",
"name": "La myomectomie peut-elle affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la myomectomie peut affecter la fertilité, mais elle préserve souvent l'utérus."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infection après une myomectomie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections peuvent survenir, mais elles sont généralement rares avec des soins appropriés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des saignements après la myomectomie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements peuvent survenir après l'intervention, mais ils doivent être surveillés."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des douleurs chroniques ou des problèmes menstruels."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des fibromes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'obésité, les antécédents familiaux et les hormones."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les fibromes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille avec des fibromes augmente le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les fibromes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fibromes sont plus fréquents chez les femmes de 30 à 40 ans."
}
},
{
"@type": "Question",
"name": "Le surpoids augmente-t-il le risque de fibromes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids et l'obésité sont associés à un risque accru de fibromes."
}
},
{
"@type": "Question",
"name": "Les hormones influencent-elles le développement des fibromes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les déséquilibres hormonaux, notamment des œstrogènes, peuvent favoriser leur développement."
}
}
]
}
]
}
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery (Drs. Thao, and Borah, Moriarty); Department of Obstetrics and Gynecology (Drs. Stewart and Borah); Division of Endocrinology (Dr. Stewart), Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
From St. George's Hospital and Medical School (I.M., A.-M.B.) and Whipps Cross Hospital (F.S.), London, the University of Glasgow, Glasgow (M.-A.L., J.M., O.W.), the University of Birmingham, Birmingham (W.M., L.J.M., V.C.), the University of Nottingham, Nottingham (J.P.D.), and the University of Oxford, Oxford (K.M.) - all in the United Kingdom.
Department of Obstetrics and Gynecology, Mount Sinai Hospital and Women's College Hospital; and Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
Department of Obstetrics and Gynecology, Mount Sinai Hospital and Women's College Hospital; and Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada. Electronic address: ally.murji@sinaihealthsystem.ca.
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Biostatistics, Yale School of Public Health, New Haven CT. Electronic address: ranchan@bwh.harvard.edu.
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC.
A uterine diverticulum is defined as the presence of a niche within the inner contour of the uterine myometrial wall. Although secondary uterine diverticula can occur after hysterotomy such as cesarea...
A 45-year-old nulliparous woman undergoing infertility treatment was referred to our hospital because of abnormal postmenstrual bleeding after myomectomy. Transvaginal sonography and magnetic resonanc...
This report highlights the similarities of the patient's diverticulum to cesarean scar defects in terms of symptoms and pathophysiology. First, this patient developed a diverticulum with hypervascular...
Increasing evidence suggests that hysterectomy to treat uterine fibroids (UFs), even with ovarian conservation (OC), is associated with a 33% increased risk of coronary artery disease (CAD). We sought...
We developed a Markov model to include women with UFs who no longer desired pregnancy. The outcomes of interest were quality-adjusted life-years (QALYs) and total treatment costs. We conducted sensiti...
Health system perspective....
A hypothetical cohort of 10 000 40-year-old women....
Myomectomy, hysterectomy with OC, and hysterectomy without OC....
Myomectomy was the best-value strategy, costing US$528 217 and providing 19.38 QALYs. Neither hysterectomy with OC nor hysterectomy without OC was found to be cost-effective, assuming a willingness-to...
Myomectomy is an optimal treatment of UFs compared with hysterectomy among women aged 40 years. The increased risk of CAD after hysterectomy and its associated costs and the effects on morbidity and q...
Focused ultrasound ablation surgery (FUAS) has been widely employed to treat patients with uterine fibroid (UF). This study aimed to estimate myometrial stiffness changes in patients who received FUAS...
This study enrolled 173 patients from May 2022 to August 2023. Shear wave elastography (SWE) was used to dynamically monitor myometrial elasticity changes in patients before and after surgery. Moreove...
The stiffness of the myometrium around the resected fibroid was significantly higher than at the preoperative level until 6 months. Conversely, the stiffness of the surrounding myometrium was only tem...
The FUAS had less impact on the surrounding myometrium than the ME, which may be more conducive to the recovery of myometrial elasticity in patients with UF....
This review compares the efficacy of Uterine Artery Embolization (UAE) and Myomectomy (MYO) in managing symptomatic Uterine Fibroids (UFs) in women who do not want hysterectomy. A meta-analysis was pe...
This study aimed to compare the effect of triple uterine tourniquet and single tourniquet on intraoperative blood loss during open myomectomy....
Women were randomized to undergo open myomectomy with a triple (n = 30) or single uterine tourniquet (n = 30). All symptomatic women aged 18-48 who had three or more myomas or at least one myoma great...
We found no significant difference in intraoperative blood loss between triple and single uterine tourniquets (527 [102-2931]) ml vs. 508 [172-2764] ml, p = 0.238). Between the single and triple tourn...
There was no clinically significant difference in intraoperative blood loss between triple and single uterine tourniquets during open myomectomy....
ClinicalTrials.gov ID: NCT02392585, 03/13/2015....
At time of myomectomy, a surgical procedure to remove uterine fibroids, Black women tend to have larger uteri than White women. This makes Black patients less likely to undergo a minimally invasive my...
We conducted a secondary data analysis of patients with fibroids scheduled for myomectomy using data from a fibroid treatment registry in [location]. We used validated measures of individual-level Fin...
Black participants had worse financial toxicity, greater deprivation and larger uterine volumes compared with White participants. A greater Financial Toxicity score (better financial status) was assoc...
Disproportionately worse Financial Toxicity and ADI among Black patients is likely due to structural racism - which now must be considered in gynecologic research and practice....
Not applicable....
Few studies have directly compared different surgical procedures for uterine fibroids with respect to long-term health-related quality of life outcomes and symptom improvement....
We examined differences in change from baseline to 1-, 2-, and 3-year follow-up in health-related quality of life and symptom severity among patients who underwent abdominal myomectomy, laparoscopic o...
The COMPARE-UF registry is a multiinstitutional prospective observational cohort study of women undergoing treatment for uterine fibroids. A subset of 1384 women aged 31 to 45 years who underwent eith...
At baseline, women undergoing hysterectomy and uterine artery embolization reported the lowest health-related quality of life scores and highest symptom severity scores compared with those undergoing ...
All treatment modalities were associated with significant improvements in health-related quality of life and symptom severity reduction 1-year posttreatment. However, abdominal myomectomy, laparoscopi...
Fibroids are the most common benign tumours of the uterus, often requiring surgery when symptomatic. This study aims to investigate the impact of surgery using two methods, laparoscopy and laparotomy,...
To assess outcomes of planned pre-operative uterine artery embolization (UAE) in patients with uterine fibroids at high risk for bleeding prior to hysterectomy or myomectomy....
A retrospective review of 53 consecutive patients who underwent planned UAE followed by surgery from 2004 to 2019 was performed in a subset of patients deemed high risk for bleeding by the referring s...
53 patients (mean age = 41) had an elective UAE prior to a hysterectomy 24 (45%) or myomectomy 29 (55%). Median interval between UAE & surgery was 21.6 h (range 1.75 h-57 days). Of the myomectomies, 1...
Planned pre-operative UAE resulted in intraoperative blood loss similar to "all-comer" myomectomy and hysterectomy patients in the literature. Further studies may elucidate which patients would be the...
The oral gonadotropin-releasing hormone antagonist relugolix, which temporarily stops menstruation, is used to treat heavy menstrual bleeding, pelvic pressure, and low back pain in women with uterine ...
Efficacy and safety of preoperative administration of drugs will be studied in a multi-center, randomized, open-label, parallel-group, noninferiority trial enrolling premenopausal women ≥ 20 years of ...
Real-world evidence will be collected in a clinical setting to use pre-treatment with an oral gonadotropin-releasing hormone antagonist to reduce intraoperative bleeding in women who undergo laparosco...
jRCTs031210564 was registered on 19 January 2022 in the Japan Registry of Clinical Trials ( https://jrct.niph.go.jp )....
